Cara Therapeutics Inc. (69C)
Market Closed
17 Jul, 20:00
XMUN 
€
2. 64
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-2.04 Eps
€ 2.64
Previous Close Want to track 69C and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cara Therapeutics Inc. (69C) Statistics
Valuation metrics
Market Cap -
Enterprise value -20.53M
Trailing P/E (ttm) -1.42
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) -
Price/Book (mrq) 1.56
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.77
Overview
Shares outstanding 9.38M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 30
Average volume (90 days) 10
Price summary
52-Week low 1.62
52-Week high 37.9
Beta -
50-Day moving average 2.94
200-Day moving average 9.44
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:12
Last split Date 2 Jan 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.57%
Return on equity -0.87%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -18.21M
Diluted EPS (ttm) -3.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 201K
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 2.86%
Book value per share (mrq) 2.25
Cash Flow
Cash flow statement -16.1M
Levered free cash flow (LFCF) -18.21M
